New Delhi: Amid the rollout of the world’s largest Covid-19 vaccination programme by Prime Minister Narendra Modi, here are a few things that you need to know about the two vaccines — ‘Covaxin’ and ‘Covishield’ — selected by the Drugs Controller General of India (DCGI).
So far, the government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.
Covaxin, developed by Hyderabad-based Bharat Biotech, is the country’s first indigenous vaccine against the virus and it has been developed with the help of the Indian Council of Medical Research (ICMR) and National Institute of Virology.
Covaxin uses an inactivated form of the coronavirus. It destroys the ability of the virus to multiply in the human body and increases immunity system to fight the virus.
The adverse events following immunisation (AEFIs) of Covaxin include injection site pain, swelling, headache, fatigue, fever, body ache, abdominal…